Redhill Biopharma
RDHL
#11160
Rank
โ‚ฌ2.27 M
Marketcap
0,26ย โ‚ฌ
Share price
-13.08%
Change (1 day)
-71.59%
Change (1 year)

Redhill Biopharma (RDHL) - Cash on Hand

Cash on Hand as of June 2026 : โ‚ฌ4.7 Million

According to Redhill Biopharma's latest financial reports the company has โ‚ฌ4.7 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Redhill Biopharma - Cash on Hand chart (from 2011 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚ฌ3.38 M-23.81%
2024-12-31โ‚ฌ4.43 M-11.93%
2023-12-31โ‚ฌ5.03 M-72.96%
2022-12-31โ‚ฌ18.62 M-44.49%
2021-12-31โ‚ฌ33.55 M38.54%
2020-12-31โ‚ฌ24.22 M-43.32%
2019-12-31โ‚ฌ42.73 M-8.08%
2018-12-31โ‚ฌ46.49 M20.73%
2017-12-31โ‚ฌ38.5 M-38.77%
2016-12-31โ‚ฌ62.89 M18.28%
2015-12-31โ‚ฌ53.17 M181.84%
2014-12-31โ‚ฌ18.86 M115.09%
2013-12-31โ‚ฌ8.77 M-36.82%
2012-12-31โ‚ฌ13.88 M-3.31%
2011-12-31โ‚ฌ14.35 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Sanofi
SNY
โ‚ฌ6.60 B 140,381.68%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚ฌ6.50 B 138,318.30%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚ฌ3.58 B 76,056.23%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
โ‚ฌ3.33 B 70,747.06%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
โ‚ฌ0.82 B 17,388.20%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel